Launch of National Drugs Strategy Consultation
Minister of State for Communities and the National Drugs Strategy, Catherine Byrne TD, has announced details of a public consultation on the new National Drugs Strategy.
The strategy will set out Government policy on tackling drug problems from 2017 onwards.
Minister Byrne said: “The development of the new National Drugs Strategy is essential to ensure that we have an up-to-date and effective response to the drug problem facing our society. We are planning for a future where Ireland is a better place in terms of drug prevention, where people can make informed decisions through education, and the right services and support are provided to those who need them most. Now is the chance to have your say and inform Government policy on this key issue”.
The public consultation process will run for 6 weeks, from Tuesday 6th September until 5pm on Tuesday, 18th October 2016.
During the consultation, the Department is seeking the public viewpoint and for all interested parties on the drugs situation in Ireland to help inform the new Strategy.
At the end of the public consultation, the views received will be compiled in a report to assist in the development of the new Strategy.
“Drug” includes a wide range of substances including illicit (or illegal) drugs, prescription medicines,
over the counter medicines (OTCs) – medicines, solvents and alcohol.
You can provide your views in one of the following ways:
Using the questionnaire, complete online at or complete and return to the P.O. Box address provided below
Write to : National Drugs Strategy, PO Box 12778, Glenageary, Co Dublin
Call : 1890 10 00 53
The questionnaire is available in:
Public consultation meetings on the new Strategy will take place in Carrick-on-Shannon, Limerick, Cork and Dublin. To register your interest in attending these events, please email firstname.lastname@example.org.
If you have any difficulty completing the online questionnaire or would like to request a printed copy, please contact us using the details above.